Back to search

Article

Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders

2025-02-18

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Immune checkpoint inhibitors (ICIs) have greatly improved the prognosis of advanced melanoma. However, the efficacy of ICIs in Japanese patients has been found to be lower than that in Caucasians. We aimed to elucidate the genomic and transcriptomic features associated with the response to ICIs in Japanese patients with melanoma. <bold>Patients and methods</bold>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9b69793b-7a96-5f9c-98dc-94aba73dfadc
DOI
10.21203/rs.3.rs-5997977/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor respondersDOI 10.21203/rs.3.rs-5997977/v1
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanomaSemantic proximity
Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis.Semantic proximity
Association of EYS mutations with immune checkpoint inhibitor outcome and response in melanoma and non-small cell lung cancerSemantic proximity
Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma.Semantic proximity
Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity
Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future PerspectivesSemantic proximity
Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes.Semantic proximity
Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma.Semantic proximity
The combination of single-cell and bulk RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genesSemantic proximity
Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal MelanomaSemantic proximity
A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironmentSemantic proximity
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanomaSemantic proximity
Select a neighboring publication to make it the new centre.